Quick Answer
TANDEM DIABETES CARE INC reported Earnings Per Share Diluted of $3.04 (loss) per share for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -106.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $0.62 (loss) per share | Q3 2019: $0.09 (loss) per share | Q2 2020: $0.45 (loss) per share | Q3 2020: $0.15 (loss) per share | Q4 2020: $0.22 per share | Q1 2021: $0.08 (loss) per share | Q2 2021: $0.06 per share | Q3 2021: $0.09 per share | Q4 2021: $0.16 per share | Q1 2022: $0.23 (loss) per share | Q2 2022: $0.24 (loss) per share | Q3 2022: $0.76 (loss) per share | Q4 2022: $0.25 (loss) per share | Q1 2023: $1.92 (loss) per share | Q2 2023: $0.55 (loss) per share | Q3 2023: $0.51 (loss) per share | Q4 2023: $0.46 (loss) per share | Q1 2024: $0.65 (loss) per share | Q2 2024: $0.47 (loss) per share | Q3 2024: $0.35 (loss) per share | Q4 2024: $0.01 per share | Q1 2025: $1.97 (loss) per share | Q2 2025: $0.78 (loss) per share | Q3 2025: $0.31 (loss) per share | Q4 2025: $0.01 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), TANDEM DIABETES CARE INC's Earnings Per Share Diluted has declined by 623.8%.
- Historical annual values: Fiscal year 2025: $3.04 (loss) per share | Fiscal year 2024: $1.47 (loss) per share | Fiscal year 2023: $3.43 (loss) per share | Fiscal year 2022: $1.47 (loss) per share | Fiscal year 2021: $0.24 per share | Fiscal year 2020: $0.56 (loss) per share | Fiscal year 2019: $0.42 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: